European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative

ÖZEN, SEZA; Marks, Stephen; Brogan, Paul; Groot, Noortje; de Graeff, Nienke; Avcin, Tadej; Bader-Meunier, Brigitte; Dolezalova, Pavla; Feldman, Brian; Kone-Paut, Isabelle; Lahdenne, Pekka; McCann, Liza; Pilkington, Clarissa; Ravelli, Angelo; van Royen, Annet; Uziel, Yosef; Vastert, Bas; Wulffraat, Nico; Kamphuis, Sylvia; Beresford, Michael

doi:10.1093/rheumatology/kez041

European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative

Atıf İçin Kopyala

ÖZEN S., Marks S. D., Brogan P., Groot N., de Graeff N., Avcin T., ...Daha Fazla

RHEUMATOLOGY, cilt.58, sa.9, ss.1607-1616, 2019 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 58 Sayı: 9
Basım Tarihi: 2019
Doi Numarası: 10.1093/rheumatology/kez041
Dergi Adı: RHEUMATOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1607-1616
Hacettepe Üniversitesi Adresli: Evet

Özet

Objectives. IgA vasculitis (IgAV, formerly known as Henoch-Schonlein purpura) is the most common cause of systemic vasculitis in childhood. To date, there are no internationally agreed, evidence-based guidelines concerning the appropriate diagnosis and treatment of IgAV in children. Accordingly, treatment regimens differ widely. The European initiative SHARE (Single Hub and Access point for paediatric Rheumatology in Europe) aims to optimize care for children with rheumatic diseases. The aim therefore was to provide internationally agreed consensus recommendations for diagnosis and treatment for children with IgAV.